0000000000335748

AUTHOR

Olivier Humbert

showing 15 related works from this author

GridNet with Automatic Shape Prior Registration for Automatic MRI Cardiac Segmentation

2018

In this paper, we propose a fully automatic MRI cardiac segmentation method based on a novel deep convolutional neural network (CNN) designed for the 2017 ACDC MICCAI challenge. The novelty of our network comes with its embedded shape prior and its loss function tailored to the cardiac anatomy. Our model includes a cardiac center-of-mass regression module which allows for an automatic shape prior registration. Also, since our method processes raw MR images without any manual preprocessing and/or image cropping, our CNN learns both high-level features (useful to distinguish the heart from other organs with a similar shape) and low-level features (useful to get accurate segmentation results).…

Cardiac anatomybusiness.industryComputer scienceComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONNovelty030204 cardiovascular system & hematologyGridConvolutional neural networkAccurate segmentation030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineFully automaticPreprocessorSegmentationComputer visionArtificial intelligencebusiness
researchProduct

Dual Diagnostic Role of 123I-MIBG Scintigraphy in Inverted Takotsubo Cardiomyopathy : Reply [Letter]

2016

International audience

medicine.medical_specialty[SDV]Life Sciences [q-bio]123i mibg scintigraphyCardiomyopathy[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine3-Iodobenzylguanidine030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineTakotsubo CardiomyopathyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingRadionuclide imaging[ SDV.IB ] Life Sciences [q-bio]/BioengineeringRadionuclide ImagingComputingMilieux_MISCELLANEOUS[ SDV ] Life Sciences [q-bio]business.industryGeneral Medicinemedicine.disease3. Good health3-Iodobenzylguanidine030220 oncology & carcinogenesisCardiology[SDV.IB]Life Sciences [q-bio]/BioengineeringNuclear medicinebusiness
researchProduct

18F-FDG PET-Derived Tumor Blood Flow Changes After 1 Cycle of Neoadjuvant Chemotherapy Predicts Outcome in Triple-Negative Breast Cancer

2016

International audience; Previous studies have suggested that early changes in blood flow (BF) in response to neoadjuvant chemotherapy and evaluated with 150-water are a surrogate biomarker of outcome in women with breast cancer. This study investigates, in the triple-negative breast cancer subtype, the prognostic relevance of tumor BF changes (Delta BF) in response to chemotherapy, assessed using a short dynamic F-18-FDG PET acquisition. Methods: Forty-six consecutive women with triple-negative breast cancer and an indication for neoadjuvant chemotherapy were prospectively included. Women benefited from a baseline F-18-FDG PET examination with a 2-min chest-centered dynamic acquisition, sta…

Oncologymedicine.medical_specialtyPrognostic-FactorsBevacizumabSurvival[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatment[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineperfusion[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBreast cancerbreast cancerInternal medicineMedicineblood flowRadiology Nuclear Medicine and imaging[ SDV.IB ] Life Sciences [q-bio]/BioengineeringTomography[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingNeoadjuvant therapyTriple-negative breast cancerSubtypesMarkersChemotherapytriple-negativemedicine.diagnostic_testbusiness.industryTriple Negative Breast Neoplasmsmedicine.disease3. Good healthBevacizumabPETMetabolismPositron emission tomography030220 oncology & carcinogenesisBiomarker (medicine)Pathological Response[SDV.IB]Life Sciences [q-bio]/BioengineeringAngiogenesisTherapybusinessmedicine.drug
researchProduct

Deep Learning Techniques for Automatic MRI Cardiac Multi-Structures Segmentation and Diagnosis: Is the Problem Solved?

2018

Delineation of the left ventricular cavity, myocardium, and right ventricle from cardiac magnetic resonance images (multi-slice 2-D cine MRI) is a common clinical task to establish diagnosis. The automation of the corresponding tasks has thus been the subject of intense research over the past decades. In this paper, we introduce the “Automatic Cardiac Diagnosis Challenge” dataset (ACDC), the largest publicly available and fully annotated dataset for the purpose of cardiac MRI (CMR) assessment. The dataset contains data from 150 multi-equipments CMRI recordings with reference measurements and classification from two medical experts. The overarching objective of this paper is to measure how f…

MaleDatabases FactualHeart DiseasesComputer science[SDV]Life Sciences [q-bio]Lleft and right ventricles030218 nuclear medicine & medical imagingTask (project management)Cardiac segmentation and diagnosis03 medical and health sciences0302 clinical medicineDeep LearningImage Interpretation Computer-AssistedmedicineMedical imagingHumansSegmentationElectrical and Electronic EngineeringRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryMyocardiumDeep learningMagnetic resonance imagingPattern recognitionHeartImage segmentationMagnetic Resonance ImagingComputer Science ApplicationsCardiac Imaging Techniquesmedicine.anatomical_structureVentricleFemaleArtificial intelligencebusinessCardiac magnetic resonanceLeft and right ventricles030217 neurology & neurosurgerySoftwareMRIIEEE transactions on medical imaging
researchProduct

18F-FDG PET imaging of breast cancer : evaluation of the metabolic behaviour of the different breast cancer subtypes and prediction of the tumor resp…

2015

Positron Emission Tomography (PET) with 18Fluoro-deoxyglucose (18F-FDG) is the reference imaging examination for in-vivo quantification of the glucidic metabolism of tumour cells. It allows for the monitoring of tumour metabolic changes during chemotherapy. Breast cancer comprises several distinct genomic entities with different biological characteristics and clinical behaviours, leading to different tailored treatments. The aim of this doctoral thesis was to evaluate the relationship between the different biological entities of breast cancer and the tumour metabolic behaviour during neoadjuvant chemotherapy. We have also retrieved, among the various metabolic parameters on PET images, the …

Subtypes[SDV.IB] Life Sciences [q-bio]/BioengineeringFDGPositon EmissionTomographyRéponse tumoraleNeoadjuvant chemotherapyPhénotypesPETBreast cancerTEP[SDV.CAN] Life Sciences [q-bio]/CancerÉvaluationTomographie par Emission de PositonChimiothérapie néoadjucanteTumor responseCancer du sein[SPI.SIGNAL] Engineering Sciences [physics]/Signal and Image processing
researchProduct

Dual Diagnostic Role of 123I-MIBG Scintigraphy in Inverted-Takotsubo Pattern Cardiomyopathy

2015

We highlight the dual role of I-MIBG scintigraphy in inverted-Takotsubo pattern cardiomyopathy, the diagnosis of which is sometimes challenging: Firstly, I-MIBG scintigraphy can show myocardial sympathetic dysfunction (low I-MIBG uptake) in the hypokinetic basal segments, sparing the left ventricle apex. It is helpful in the imaging diagnosis of inverted-Takotsubo pattern cardiomyopathy and confirms that acute dysfunction of myocardial sympathetic nerve endings occurs with this cardiomyopathy. Secondly, I-MIBG scintigraphy is an accurate imaging examination to detect and localize pheochromocytoma; it can help in the search for an endogenous cause of this adrenergic stress-related cardiomyop…

AdultMalemedicine.medical_specialtyCardiomyopathy123i mibg scintigraphyAdrenergic[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine030204 cardiovascular system & hematologyScintigraphy3-Iodobenzylguanidine030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicinePheochromocytoma03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineTakotsubo CardiomyopathyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingComputingMilieux_MISCELLANEOUSmedicine.diagnostic_testbusiness.industryGeneral Medicinemedicine.disease3. Good health3-IodobenzylguanidinePositron emission tomographyPositron-Emission TomographyCardiologyRadiopharmaceuticalsbusiness
researchProduct

Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes

2012

BACKGROUND The aim of this study is to evaluate the impact of the different breast cancer subtypes on the tumor (18)F-FDG uptake at baseline and on its changes after the first course of neoadjuvant chemotherapy (NAC). PATIENTS AND METHODS One hundred and fifteen women with newly diagnosed, large or locally advanced breast cancer undergoing NAC were included. Estrogen receptor (ER), progesterone receptor (PR) and HER2 status were used to define three major tumor subtypes: triple negative (TN) (ER-/PR-/HER2-), luminal (ER+ and/or PR+; HER2-) and HER2 positive (HER2+). Using Fluorine-18 fluorodeoxyglucose positron emission tomography, the tumoral standard uptake value (SUV) maximal index was m…

CA15-3Oncologymedicine.medical_specialtymedicine.medical_treatmentEstrogen receptorStandardized uptake valueAntineoplastic AgentsBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineMultimodal Imaging030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18Internal medicineProgesterone receptormedicineHumansskin and connective tissue diseasesPathologicalComputingMilieux_MISCELLANEOUSChemotherapybusiness.industryHematologyMetabolismmedicine.disease3. Good healthOncologyChemotherapy Adjuvant030220 oncology & carcinogenesisPositron-Emission TomographyFemalebusinessTomography X-Ray Computed
researchProduct

18F-Choline PET/CT and multiparametric MRI for the detection of local recurrence of prostate cancer initially treated by radiotherapy: comparison wit…

2016

International audience

[SDV.IB] Life Sciences [q-bio]/Bioengineering[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB]Life Sciences [q-bio]/Bioengineering[ SDV.IB ] Life Sciences [q-bio]/Bioengineering[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingComputingMilieux_MISCELLANEOUS[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct

Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer

2015

Abstract This review considers the potential utility of positron emission tomography (PET) tracers in the setting of response monitoring in breast cancer, with a special emphasis on glucose metabolic changes assessed with 18F-fluorodeoxyglucose (FDG). In the neoadjuvant setting of breast cancer, the metabolic response can predict the final complete pathologic response after the first cycles of chemotherapy. Because tumor metabolic behavior highly depends on cancer subtype, studies are ongoing to define the optimal metabolic criteria of tumor response in each subtype. The recent multicentric randomized AVATAXHER trial has suggested, in the human epidermal growth factor 2-positive subtype, a …

OncologyCancer Researchmedicine.medical_specialtyPathologyResponse to therapyReceptor ErbB-2medicine.medical_treatmentBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineHealth outcomesTumor response030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18Internal medicineBreast CancerHumansMedicineskin and connective tissue diseasesComputingMilieux_MISCELLANEOUSChemotherapymedicine.diagnostic_testbusiness.industryTumor biologyCancerPrognosismedicine.disease3. Good healthRadiographyOncologyPositron emission tomographyPositron-Emission Tomography030220 oncology & carcinogenesisFemalebusiness
researchProduct

Graph cut-based method for segmenting the left ventricle from MRI or echocardiographic images

2017

International audience; In this paper, we present a fast and interactive graph cut method for 3D segmentation of the endocardial wall of the left ventricle (LV) adapted to work on two of the most widely used modalities: magnetic resonance imaging (MRI) and echocardiography. Our method accounts for the fundamentally different nature of both modalities: 3D echocardiographic images have a low contrast, a poor signal-to-noise ratio and frequent signal drop, while MR images are more detailed but also cluttered and contain highly anisotropic voxels. The main characteristic of our method is to work in a 3D Bezier coordinate system instead of the original Euclidean space. This comes with several ad…

Convex hullHeart VentriclesEnergy MinimizationCoordinate systemEchocardiography Three-DimensionalHealth InformaticsBézier curve02 engineering and technology[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicinecomputer.software_genreAutomated Segmentation030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine03 medical and health sciences0302 clinical medicineVoxelCut0202 electrical engineering electronic engineering information engineering[INFO.INFO-IM]Computer Science [cs]/Medical ImagingMagnetic-Resonance ImagesHumansRadiology Nuclear Medicine and imagingComputer vision[ SDV.IB ] Life Sciences [q-bio]/BioengineeringCardiac MriImage gradientMathematicsWhole MyocardiumLeft ventricular 3-D segmentationRadiological and Ultrasound Technology[ INFO.INFO-IM ] Computer Science [cs]/Medical ImagingEuclidean spacebusiness.industryComputer Graphics and Computer-Aided DesignMagnetic Resonance ImagingEchocardiographyConstrained Level-SetGraph (abstract data type)020201 artificial intelligence & image processing[SDV.IB]Life Sciences [q-bio]/BioengineeringComputer Vision and Pattern RecognitionArtificial intelligencebusiness2d-EchocardiographycomputerAlgorithmsGraph cutMRI
researchProduct

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors

2012

The purpose of this study was to prospectively evaluate the relationship between tumor blood flow and glucose metabolism as evaluated by dynamic first-pass (18)F-FDG PET and by proliferation and endothelial pathologic markers in the setting of newly diagnosed breast cancer.Forty patients were prospectively included. Biopsy samples of each tumor were used to assess the Ki67 index of proliferation and immunostaining for CD34 (a panendothelial cell marker) and CD105 (a proliferation-related endothelial cell marker). All patients underwent (18)F-FDG PET/CT at least 1 wk after sample biopsy and before any treatment. A dynamic 2-min acquisition was performed immediately after intravenous injectio…

AdultPathologymedicine.medical_specialtyAngiogenesisStandardized uptake valueBreast Neoplasms[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicineMultimodal Imaging030218 nuclear medicine & medical imaging[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicineNeovascularization03 medical and health sciences0302 clinical medicineBreast cancerFluorodeoxyglucose F18BiopsymedicineBiomarkers Tumor[INFO.INFO-IM]Computer Science [cs]/Medical ImagingHumansRadiology Nuclear Medicine and imagingProspective StudiesComputingMilieux_MISCELLANEOUSAgedCell Proliferationmedicine.diagnostic_testNeovascularization Pathologicbusiness.industryEndothelial CellsBlood flowEndoglinMiddle Agedmedicine.diseasePrognosisLogistic ModelsPositron emission tomography030220 oncology & carcinogenesisPositron-Emission TomographyBlood CirculationFemalemedicine.symptombusinessTomography X-Ray Computed
researchProduct

Dual Diagnostic Role of I-123-MIBG Scintigraphy in Inverted Takotsubo Cardiomyopathy: Reply

2016

International audience

[SDV.IB] Life Sciences [q-bio]/Bioengineering[SDV.IB.IMA] Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imaging[SDV.IB]Life Sciences [q-bio]/Bioengineering[ SDV.IB ] Life Sciences [q-bio]/Bioengineering[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.IMA ] Life Sciences [q-bio]/Bioengineering/ImagingComputingMilieux_MISCELLANEOUS[SDV.IB.MN] Life Sciences [q-bio]/Bioengineering/Nuclear medicine[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicine
researchProduct

Influence of Software Tool and Methodological Aspects of Total Metabolic Tumor Volume Calculation on Baseline [18F]FDG PET to Predict Survival in Hod…

2015

Aim To investigate the respective influence of software tool and total metabolic tumor volume (TMTV0) calculation method on prognostic stratification of baseline 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography ([18F]FDG-PET) in newly diagnosed Hodgkin lymphoma (HL). Methods 59 patients with newly diagnosed HL were retrospectively included. [18F]FDG-PET was performed before any treatment. Four sets of TMTV0 were calculated with Beth Israel (BI) software: based on an absolute threshold selecting voxel with standardized uptake value (SUV) >2.5 (TMTV02.5), applying a per-lesion threshold of 41% of the SUVmax (TMTV041) and using a per-patient adapted threshold based on SUVmax of the…

AdultMaleAdolescentAbsolute thresholdlcsh:MedicineGlucose-6-PhosphateStandardized uptake valueDisease-Free SurvivalPredictive Value of TestsImage Processing Computer-AssistedmedicineHumansProgression-free survivallcsh:ScienceSurvival rateAgedMultidisciplinarymedicine.diagnostic_testReceiver operating characteristicbusiness.industrylcsh:RMiddle AgedHodgkin DiseaseRadiographySurvival RatePositron emission tomographyPositron-Emission TomographyPredictive value of testsHodgkin lymphomalcsh:QFemaleNuclear medicinebusinessSoftwareResearch ArticleFollow-Up StudiesPLOS ONE
researchProduct

Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer.

2015

Abstract Purpose: To investigate the value of the metabolic tumor response assessed with 18F-fluorodeoxyglucose positron emission tomography (FDG-PET), compared with clinicobiologic markers to predict pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in women with triple-negative breast cancer (TNBC). Experimental Design: Fifty consecutive women with TNBC and an indication for NAC were prospectively included. Different pretreatment clinical, biologic, and pathologic biomarkers, including SBR grade, the Ki-67 proliferation index, androgen receptor expression, EGF receptor (EGFR), and cytokeratin 5/6 staining, were assessed. Tumor glucose metabolism at baseline and its chan…

OncologyAdultCancer Researchmedicine.medical_specialtyPathologyProliferation indexmedicine.medical_treatmentBiopsyTriple Negative Breast NeoplasmsBreast cancerFluorodeoxyglucose F18Internal medicineBiopsyAntineoplastic Combined Chemotherapy ProtocolsmedicineBiomarkers TumorHumansEpidermal growth factor receptorTriple-negative breast cancerNeoadjuvant therapyAgedNeoplasm StagingChemotherapymedicine.diagnostic_testbiologybusiness.industryOdds ratioMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyNeoadjuvant TherapyTumor BurdenGlucoseTreatment OutcomeOncologyROC CurveLymphatic MetastasisPositron-Emission Tomographybiology.proteinFemaleNeoplasm GradingbusinessTomography X-Ray ComputedBiomarkersClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Impact of molecular and histological subtype of breast cancer on 18FDG-PET/CT imaging: Knowledge gained from recent studies

2016

International audience; Over the past few years, several studies have focused attention on the impact of breast cancer (BC) histological subtype or BC phenotype, as defined by hormone receptors (HR) and HER2 status, on the results of FDG-PET/CT at staging, or during neoadjuvant chemotherapy (NAC). At staging, sclerotic bone metastases from invasive lobular carcinoma (ILC) demonstrated low or no FDG uptake in comparison to metastases from invasive ductal carcinoma (IDC). The CT component of PET/CT imaging should be carefully analyzed in the staging of ILC. In patients with triple negative or HER2-positive tumors, the proportion of extraskeletal metastases is high; this must be taken into acc…

Oncologymedicine.medical_specialtyPathologyStagingPET/CTmedicine.medical_treatmentBiophysicsEstrogen receptorER-positive breast cancerNeoadjuvant chemotherapy030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineBreast cancerBreast cancerTriple-negative breast cancerResponse assessmentInternal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyMedicineRadiology Nuclear Medicine and imagingskin and connective tissue diseasesHER2-positive breast cancerTriple-negative breast cancerChemotherapyPET-CTPathological complete responseRadiological and Ultrasound Technologybusiness.industrymedicine.disease18fdg pet ctPrognosis3. Good healthHormone receptor030220 oncology & carcinogenesisInvasive lobular carcinoma(18)FDGbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct